Literature DB >> 25921969

Life-threatening flecainide overdose treated with intralipid and extracorporeal membrane oxygenation.

Emily Brumfield1, Kenneth R L Bernard2, Christopher Kabrhel3.   

Abstract

Flecainide is a Class Ic antiarrythmic agent associated with adverse events due to its pro-arrythmic effects. We report the case of a 33-year-old female presenting in cardiac arrest after a flecainide overdose treated with intravenous fat emulsion (IFE), sodium bicarbonate (NaHCO₃), and extracorporeal membrane oxygenation (ECMO). This case reviews the pathophysiology and management of flecainide toxicity including novel strategies of IFE and ECMO.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25921969     DOI： 10.1016/j.ajem.2015.04.012

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


  5 in total

1.  Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning.

Authors:  Jon B Cole; Justin N Corcoran; Kristin M Engebretsen; Samuel J Stellpflug
Journal:  J Med Toxicol       Date:  2020-01-24

2.  Examining the role of extracorporeal membrane oxygenation in patients following suspected or confirmed suicide attempts: A case series.

Authors:  Adeel Abbasi; Cynthia Devers; Christopher S Muratore; Colin Harrington; Corey E Ventetuolo
Journal:  J Crit Care       Date:  2017-10-18       Impact factor: 3.425

3.  Management of life-threatening flecainide overdose: A case report and review of the literature.

Authors:  Nancy M Vu; Terence E Hill; Matthew R Summers; Michael N Vranian; Michael D Faulx
Journal:  HeartRhythm Case Rep       Date:  2015-12-29

4.  Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption.

Authors:  Nicolas De Schryver; Philippe Hantson; Vincent Haufroid; Mélanie Dechamps
Journal:  Case Rep Cardiol       Date:  2019-07-24

5.  A Case Report of Flecainide Toxicity With Review of Literature.

Authors:  Pratik Khatiwada; Lindsey Clark; Arjun Khunger; Bhimesh B Rijal; Jody Ritter
Journal:  Cureus       Date:  2022-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.